Skip to Main content Skip to Navigation
Journal articles

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions

Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03152735
Contributor : Jacques Nunès <>
Submitted on : Thursday, February 25, 2021 - 6:26:39 PM
Last modification on : Friday, February 26, 2021 - 3:18:51 AM

Links full text

Identifiers

Collections

Citation

Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Camillo Porta, Daniel Olive, et al.. Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions. OncoImmunology, Taylor & Francis, 2020, 9 (1), pp.1832348. ⟨10.1080/2162402X.2020.1832348⟩. ⟨hal-03152735⟩

Share

Metrics

Record views

8